Mangoceuticals Financial Statements From 2010 to 2026

Stocks USA . 
Stock . Mangoceuticals Common Stock
MGRX Stock   0.40  0.02  6.05%   
Mangoceuticals Common's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mangoceuticals Common's valuation are provided below:
Gross Profit
283 K
Market Capitalization
6.2 M
Enterprise Value Revenue
12.5363
Revenue
466.9 K
Earnings Share
(2.72)
We have found one hundred twenty available fundamental ratios for Mangoceuticals Common, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Mangoceuticals Common last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Mangoceuticals Common Total Revenue

497,312

Check Mangoceuticals Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangoceuticals Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 871.3 K, Interest Expense of 16.5 K or Selling General Administrative of 7.8 M, as well as many indicators such as Price To Sales Ratio of 8.5, Dividend Yield of 0.14 or PTB Ratio of 0.32. Mangoceuticals financial statements analysis is a perfect complement when working with Mangoceuticals Common Valuation or Volatility modules.
  
Build AI portfolio with Mangoceuticals Stock
Check out the analysis of Mangoceuticals Common Correlation against competitors.

Mangoceuticals Common Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets18.6 M17.7 M3.2 M
Slightly volatile
Short and Long Term Debt Total202.3 K247.2 K95.1 K
Slightly volatile
Total Current Liabilities1.7 M1.6 M337 K
Slightly volatile
Cash64.1 K67.5 K110.7 K
Slightly volatile
Cash And Short Term Investments64.1 K67.5 K110.7 K
Slightly volatile
Common Stock Shares Outstanding1.4 M2.3 M1.2 M
Slightly volatile
Liabilities And Stockholders Equity18.6 M17.7 M3.2 M
Slightly volatile
Other Stockholder Equity42 M40 M7.7 M
Slightly volatile
Total Liabilities1.7 M1.6 M348.4 K
Slightly volatile
Net Invested Capital17 M16.2 M2.9 M
Slightly volatile
Short and Long Term Debt130.8 K172.5 K73.1 K
Slightly volatile
Total Current Assets82.6 K86.9 K119.3 K
Slightly volatile
Capital Stock362381838
Very volatile
Short Term Debt149.1 K247.2 K80.6 K
Slightly volatile
Common Stock278292822
Very volatile
Accounts Payable1 M963.1 K199.4 K
Slightly volatile
Non Currrent Assets Other13.6 K15.2 K16.6 K
Slightly volatile
Other Assets13.6 K15.2 K16.6 K
Slightly volatile
Other Current Assets32.9 K19.5 K16.6 K
Slightly volatile
Property Plant Equipment233.4 K262.6 K286.6 K
Slightly volatile
Intangible Assets12.2 M13.7 M15 M
Slightly volatile

Mangoceuticals Common Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization871.3 K829.8 K193.7 K
Slightly volatile
Selling General Administrative7.8 M7.4 M1.6 M
Slightly volatile
Selling And Marketing Expenses1.1 M1.7 M432.7 K
Slightly volatile
Other Operating Expenses5.7 M9.9 M2.1 M
Slightly volatile
Total Operating Expenses5.5 M9.6 M2.1 M
Slightly volatile
Total Revenue497.3 K708.3 K157 K
Slightly volatile
Gross Profit299.3 K437 K94.8 K
Slightly volatile
Cost Of Revenue198 K271.3 K62.3 K
Slightly volatile
Reconciled Depreciation883.2 K841.2 K148.7 K
Slightly volatile

Mangoceuticals Common Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation883.2 K841.2 K148.9 K
Slightly volatile
Other Non Cash Items2.7 M2.5 M557 K
Slightly volatile
Total Cash From Financing Activities3.7 M4.7 M1.3 M
Slightly volatile
End Period Cash Flow64.1 K67.5 K110.7 K
Slightly volatile
Change To Netincome759.3 K723.1 K198.7 K
Slightly volatile
Stock Based Compensation406 K286 K271.1 K
Slightly volatile
Change In Working Capital797.4 K759.4 K147.3 K
Slightly volatile
Begin Period Cash Flow529.6 K849.9 K182 K
Slightly volatile
Issuance Of Capital Stock4.2 M4.6 M2.6 M
Slightly volatile
Change To Account Receivables44 K49.5 K54 K
Slightly volatile
Other Cashflows From Investing Activities52 K58.5 K63.9 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio8.58.945.9 K
Slightly volatile
Dividend Yield0.140.150.1648
Slightly volatile
Average Payables13.5 K15.2 K16.5 K
Slightly volatile
Stock Based Compensation To Revenue0.440.4620.1525
Slightly volatile
Capex To Depreciation0.150.168.5672
Slightly volatile
EV To Sales8.779.235.9 K
Slightly volatile
Inventory Turnover12.9714.5915.9284
Slightly volatile
Days Of Inventory On Hand18.0120.2622.1131
Slightly volatile
Payables Turnover0.240.250.2636
Slightly volatile
Sales General And Administrative To Revenue11.3911.99143
Slightly volatile
Average Inventory7.4 K8.3 K9.1 K
Slightly volatile
Capex To Revenue0.00530.00553.6885
Slightly volatile
Cash Per Share0.02530.02670.096
Slightly volatile
Days Payables Outstanding1.6 K1.5 K2.6 K
Slightly volatile
Income Quality0.830.640.9023
Slightly volatile
Intangibles To Total Assets0.790.890.9733
Slightly volatile
Current Ratio0.05790.0610.8003
Pretty Stable
Capex Per Share0.00360.00380.0294
Slightly volatile
Revenue Per Share0.260.280.0961
Slightly volatile
Interest Debt Per Share0.120.10.073
Slightly volatile
Debt To Assets0.01530.01611.2598
Slightly volatile
Operating Cycle18.0120.2622.1131
Slightly volatile
Days Of Payables Outstanding1.6 K1.5 K2.6 K
Slightly volatile
Ebt Per Ebit0.820.981.0011
Slightly volatile
Total Debt To Capitalization0.01660.01751.262
Slightly volatile
Quick Ratio0.05790.0610.7952
Pretty Stable
Net Income Per E B T0.80.90.9823
Slightly volatile
Cash Ratio0.0450.04730.7733
Pretty Stable
Days Of Inventory Outstanding18.0120.2622.1131
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.151.0404
Slightly volatile
Fixed Asset Turnover9.348.91.8777
Slightly volatile
Debt Ratio0.01530.01611.2598
Slightly volatile
Price Sales Ratio8.58.945.9 K
Slightly volatile
Asset Turnover0.03430.03610.0543
Slightly volatile
Gross Profit Margin0.460.560.5459
Very volatile

Mangoceuticals Common Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.8 M4.3 M4.7 M
Slightly volatile
Enterprise Value4 M4.5 M4.9 M
Slightly volatile

Mangoceuticals Fundamental Market Drivers

Mangoceuticals Upcoming Events

26th of January 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Mangoceuticals Common Financial Statements

Mangoceuticals Common investors use historical fundamental indicators, such as Mangoceuticals Common's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mangoceuticals Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue708.3 K497.3 K
Cost Of Revenue271.3 K198 K
Stock Based Compensation To Revenue 0.46  0.44 
Sales General And Administrative To Revenue 11.99  11.39 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.28  0.26 
Ebit Per Revenue(11.65)(12.23)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Mangoceuticals Stock Analysis

When running Mangoceuticals Common's price analysis, check to measure Mangoceuticals Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals Common is operating at the current time. Most of Mangoceuticals Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals Common's price. Additionally, you may evaluate how the addition of Mangoceuticals Common to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY